We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

SDC Introduces Dr. Dale W. Usner as its New Vice President of Biostatistics

Dr. Usner will be responsible for overseeing the operations of SDC's biostatistics team.
News

Expression Analysis Hires Director of Business Development

Expression Analysis announces that Jeff Fitzgerald has joined their management team as Director of Business Development.
News

Proteonomix Senior Management Meets With Investment Community

Michael Cohen and Ian McNiece met with the team at Gilford Securities and Aegis Capital.
News

Trophos Completes Patient Enrolment in Pivotal Efficacy Study of Olesoxime in SMA

Topline results expected in second half of 2013.
News

Scientists Develop Artificial Biominerals

Scientists have created synthetic crystals whose structures and properties mimic of naturally occurring biominerals.
News

Vermillion Announces Issuance of Patent for Lung Cancer

The United States Patent and Trademark Office (USPTO) has issued patent number 8,014,952 entitled " Serum Biomarkers in Lung Cancer " to the Company.
News

Critical Pharmaceuticals Announce Interim Results of CP024 Nasal hGH Phase 1 Program

Clinical data show that CP024 is able to induce IGF-1 to the same levels as a subcutaneous injection of the marketed product.
News

4SC’s Resminostat Meets Primary Efficacy Endpoint in Phase II Trial in Hodgkin’s Lymphoma

Resminostat shows substantial clinical benefit in heavily pre-treated relapsed/refractory HL patients.
News

Malvern Instruments and Purdue University Present Joint Symposium on Light Scattering Techniques for Nanoparticle Characterization

The symposium will take place on the Purdue Campus at West Lafayette, Indiana.
News

ITT Completes Acquisition of YSI Incorporated to Enhance its Water Instrumentation Business

ITT completes acquisition forming a water-focused analytics business with annual revenue of approximately $300 million.
Advertisement